JANE STREET GROUP, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 62 filers reported holding GALECTIN THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$85,096
+112.7%
40,522
+14.5%
0.00%
Q4 2022$40,000
-54.0%
35,398
-15.9%
0.00%
Q4 2021$87,000
-52.5%
42,100
-10.6%
0.00%
Q3 2021$183,000
+140.8%
47,100
+98.5%
0.00%
Q2 2021$76,000
-13.6%
23,733
-0.5%
0.00%
Q3 2019$88,000
-22.1%
23,849
+8.3%
0.00%
Q1 2019$113,000
+24.2%
22,029
+53.3%
0.00%
Q2 2018$91,000
-65.5%
14,369
-24.8%
0.00%
-100.0%
Q2 2014$264,000
+29.4%
19,096
+43.0%
0.00%
+50.0%
Q1 2014$204,00013,3510.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 129,488$248,6170.07%
Geneos Wealth Management Inc. 417,350$801,3120.04%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$23,0400.02%
RETIREMENT GUYS FORMULA LLC 11,500$22,0800.02%
Vivaldi Capital Management LP 19,261$36,9810.01%
OSAIC HOLDINGS, INC. 3,275,192$6,288,3450.01%
Traynor Capital Management, Inc. 34,707$66,6380.01%
Atria Wealth Solutions, Inc. 259,800$498,8160.01%
BARRETT & COMPANY, INC. 4,984$9,5690.01%
Wealthspire Advisors, LLC 183,862$353,0160.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders